STRYKER COMPLETES FIRST CLINICAL USE OF TORNIER PYROCARBON HUMERAL HEAD

Stryker recently announced that Armodios M. Hatzidakis, MD, FAAOS, Western Orthopaedics, PC, Denver Surgery Center and Rose Medical Center, has successfully completed the first case in the United States, since the De Novo clearance, using the Tornier Pyrocarbon Humeral Head. Stryker’s De Novo request was granted in late 2022 after completing an Investigational Device Exemption (IDE) study with the FDA.

Pyrocarbon is an advanced bearing material that has surface properties more similar to the bone than traditional orthopaedic metallic bearing surfaces. It has been utilized internationally for a variety of orthopaedic procedures since the early 1990s and in shoulder cases since 2013. Stryker is the first company to offer an FDA-cleared pyrocarbon implant for shoulder hemiarthroplasty in the U.S.

The first clinical usage of the Pyrocarbon Humeral Head for shoulder hemiarthroplasty is another milestone demonstrating Stryker's drive to provide new options for shoulder surgeons and their patients and make healthcare better.